Premium
Venture capital firm Sequoia Capital is monetising a part of its investment in a drug development company through a deal with Aurobindo Pharma Ltd, one of India’s biggest pharmaceutical companies. Hyderabad-based Aurobindo Pharma had formed a joint venture with Sequoia-backed Celon Laboratories Pvt. Ltd in 2013 and is now taking full ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
